FIRST-OF-KIND RESEARCH

We are undertaking the most extensive clinical research pipeline to assess the effects of NMN in humans to date.*
 
This pipeline is designed to gather as much diverse data as possible to assess NMN-C®’s action on a range of health- and lifespan associated conditions, including cardiovascular, cognitive, muscular, skin and immune health.**
 
*Statement based on the review of publications on PubMed as of January 1, 2021
** Elevant’s NMN-C® has not been demonstrated safe or effective for these purposes 

SENEQUE'S CLINICAL TRIAL PIPELINE

Skin anti-aging

Under preparation
Recruiting
Completed
  • Study design
  • Expected completion date

40 participants - 28 days - 5% nmn cream

Completed

Skin health

Under preparation
Recruiting
Completed
  • Study design
  • Expected completion date

60 participants - 56 days - 2% nmn cream

Completed

Physical capacity and muscle recovery

Under preparation
Recruiting
Completed
  • Study design
  • Expected completion date
150 participants - 38 days - placebo/NMN 250mg/NMN 500mg

Q4 2021

Tolerance & NAD+ levels

Under preparation
Recruiting
Completed
  • Study design
  • Expected completion date

 20 participants - 30 days - NMN 400mg

Q3 2021

Pharmacokinetics

Under preparation
Recruiting
Completed
  • Study design
  • Expected completion date

 24 participants - 30 days - NMN 400mg

Q3 2021

Lipid and glucose management

Under preparation
Recruiting
Completed
  • Study design
  • Expected completion date

80 participants - 120 days - placebo/NMN 800mg

Q3 2021

Senior healthspan extension NMN vs NR

Under preparation
Recruiting
Completed
  • Study design
  • Expected completion date
 200 participants - 360 days - placebo/NMN 750mg

Q4 2022

Severe fatigue management

Under preparation
Recruiting
Completed
  • Study design
  • Expected completion date
100 participants - 60 days - placebo/NMN 600mg

Q4 2021

Cognitive performance

Under preparation
Recruiting
Completed
  • Study design
  • Expected completion date
100 participants - 120 days - placebo/NMN 600mg

Q4 2021

Sleep quality

Under preparation
Recruiting
Completed
  • Study design
  • Expected completion date
40 participants - 30 days - NMN 400mg

Q4 2021

Immune health

Under preparation
Recruiting
Completed
  • Study design
  • Expected completion date

200 participants - 120 days - placebo/NMN 600mg

Q1 2022